Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

LATS2 is a tumor suppressor gene of malignant mesothelioma.

Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, Toyokuni S, Osada H, Sekido Y.

Cancer Res. 2011 Feb 1;71(3):873-83. doi: 10.1158/0008-5472.CAN-10-2164.

2.

Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.

Sekido Y.

Pathol Int. 2011 Jun;61(6):331-44. doi: 10.1111/j.1440-1827.2011.02666.x. Review.

PMID:
21615608
3.

Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells.

Sekido Y.

Cancer Sci. 2010 Jan;101(1):1-6. doi: 10.1111/j.1349-7006.2009.01336.x. Review.

4.

Molecular pathogenesis of malignant mesothelioma.

Sekido Y.

Carcinogenesis. 2013 Jul;34(7):1413-9. doi: 10.1093/carcin/bgt166. Review.

5.

Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.

Murthy SS, Testa JR.

J Cell Physiol. 1999 Aug;180(2):150-7. Review.

PMID:
10395284
6.

Shedding light on Merlin's wizardry.

Okada T, You L, Giancotti FG.

Trends Cell Biol. 2007 May;17(5):222-9. Review. Erratum in: Trends Cell Biol. 2008 Jan;18(1):11.

PMID:
17442573
7.

LATS tumor suppressor: a new governor of cellular homeostasis.

Visser S, Yang X.

Cell Cycle. 2010 Oct 1;9(19):3892-903. Review.

PMID:
20935475
8.

Function and cancer genomics of FAT family genes (review).

Katoh M.

Int J Oncol. 2012 Dec;41(6):1913-8. doi: 10.3892/ijo.2012.1669. Review.

Items per page

Supplemental Content

Support Center